141
GISSI-AF – Use of Valsartan an Angiotensin II AT1-Receptor Blocker in the Prevention of Atrial Fibrillation Recurrence
Condition(s):Atrial FibrillationLast Updated:April 20, 2009Completed
Valsartan: 511 Clinical Trials, Page 15 of 52
Hide Studies Not Open or Pending
142
Effect of ARNI in Patients With Persistent AF and Enlarged Left Atrium After Catheter Ablation
Condition(s):Atrial Fibrillation; Cardiac Remodeling, Atrial; Sacubitril/ValsartanLast Updated:March 19, 2019Unknown status
143
A Safety and Tolerability Study of the Combination of Aliskiren/Valsartan in Patients With High Blood Pressure, Followed by Long-term Safety and Tolerability of Aliskiren, Valsartan and Hydrochlorothiazide.
Condition(s):HypertensionLast Updated:February 10, 2014Completed
144
Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease
Condition(s):Proteinuric Kidney Disease; Diabetic Nephropathy; Hypertensive Nephrosclerosis; IgA Nephropathy; Focal Segmental Glomerulosclerosis; Glomerulopathy (Obesity-associated); Glomerulonephritis, MembranousLast Updated:May 15, 2014Terminated
145
Kanagawa Valsartan Trial (KVT): Effects of Valsartan on Renal and Cardiovascular Disease
Condition(s):Chronic Kidney Disease; HypertensionLast Updated:March 31, 2015Completed
146
The Impact of Dose of Angiotensin-receptor Blocker Valsartan and Genetic Polymorphism on the Post-MI Ventricular Remodeling
Condition(s):Myocardial InfarctionLast Updated:December 2, 2015Completed
147
Effect of Valsartan Compared to Enalapril on Sitting Systolic Blood Pressure in Children With High Blood Pressure
Condition(s):HypertensionLast Updated:May 19, 2011Completed
148
A Study to Compare Treating Hypertension With Valsartan 160 MG to Valsartan 320 Mg
Condition(s):HypertensionLast Updated:November 23, 2011Completed
149
Valsartan Optimal Therapy Against Elevated Home Blood Pressure Research（VOYAGER）Study
Condition(s):HypertensionLast Updated:December 9, 2013Completed
150
Pharmacokinetic Study of Livalo® Fixed Combination Drug in Healthy Subjects
Condition(s):Hyperlipidemia; HypertensionLast Updated:January 3, 2013Completed